As reviewed recently by our group23, the tumor-promoting roles of GSK3β involve diverse arrays of pro-oncogenic pathways, suggesting a need for future studies to clarify the distinct biological mechanism(s) by which GSK3β participates in the progression of ESCC. Here, GSK3B is linked to neoplasm.